S 3797 United States Senate · 119th Congress

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

This bill amends the Federal Food, Drug, and Cosmetic Act to add two new prohibitions for dietary supplements. It bans introducing into interstate commerce any product marketed as a dietary supplement that doesn't meet the legal definition (Section 201(ff)), and prohibits supplements prepared, packed, or held using a person banned from the industry (Section 306). These changes update import restrictions (Section 801) and seizure authorities (Section 304) to include violations of these new prohibitions. The law directly affects dietary supplement manufacturers, distributors, and sellers who handle products meeting these specific criteria.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
President
Introduced Feb 5, 2026 Last action Feb 5, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Feb 5, 2026
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)
upper
Feb 5, 2026
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor

Sponsors